Arena Pharmaceuticals Inc Revenue Growth Rates (ARNA), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Arena Pharmaceuticals Inc   (NASDAQ: ARNA)
 

ARNA's Revenue Growth by Quarter and Year

Arena Pharmaceuticals Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ARNA Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
4th Quarter December 0.05
3rd Quarter September 0.00
2nd Quarter June 0.00
1st Quarter March 0.00
FY 0.05

ARNAs Annual Revenue
Arena Pharmaceuticals Inc 's Revenue in the fiscal year 2021 $ 0.05 millions
Arena Pharmaceuticals Inc 's Revenue in the fiscal year 2019 $ 0.32 millions
Arena Pharmaceuticals Inc 's Revenue in the fiscal year 2018 $ 17.97 millions
Arena Pharmaceuticals Inc 's Revenue in the fiscal year 2017 $ 21.34 millions
Arena Pharmaceuticals Inc 's Revenue in the fiscal year 2016 $ 123.98 millions




ARNA Revenue fourth quarter 2021 Y/Y Growth Comment
Arena Pharmaceuticals Inc reported Revenue improvement of 35% year on year in the fourth quarter 2021, to $ 0.05 millions, this is lower than Arena Pharmaceuticals Inc 's recent average Revenue surge of 1628.32%.

Looking into fourth quarter 2021 results within Major Pharmaceutical Preparations industry 105 other companies have achieved higher Revenue growth. While Arena Pharmaceuticals Inc ' s Revenue rise of 35% ranks overall at the positon no. 1332 in the fourth quarter 2021.


ARNA Revenue ( Y/Y Growth %) 2021
 2020 2019 2018
4th Quarter December 35 % -98.67 % -65.32 % -43.68 %
3rd Quarter September - -98.52 % -62.18 % 47.52 %
2nd Quarter June - - -74.44 % 110 %
1st Quarter March - -99.97 % 45414.77 % 6.02 %
FY   -83.13 % -99.96 % 4387.65 % -

Financial Statements
Arena Pharmaceuticals Inc 's fourth quarter 2021 Revenue $ 0.05 millions ARNA's Income Statement
Arena Pharmaceuticals Inc 's fourth quarter 2020 Revenue $ 0.04 millions Quarterly ARNA's Income Statement


ARNA Revenue (Quarter on Quarter Growth %)

 2021
 2020 2019 2018
4th Quarter December - 100 % 122.22 % 142.3 %
3rd Quarter September - - 32.35 % -10.53 %
2nd Quarter June - - -99.87 % 126.7 %
1st Quarter March - -91.33 % 9160.81 % -88.54 %
FY (Year on Year)   -83.13 % -99.96 % 4387.65 % -


Back to ARNA Growth rate Comparisons >> Back to ARNA Growth rate Comparisons >>


Revenue fourth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #106
Healthcare Sector #219
Overall #1332

Revenue Y/Y Growth Statistics
High Average Low
45544.27 % 1628.32 % -100 %
(Mar 31 2019)   (Sep 30 2021)
Revenue fourth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #106
Healthcare Sector #219
Overall #1332
Revenue Y/Y Growth Statistics
High Average Low
45544.27 % 1628.32 % -100 %
(Mar 31 2019)   (Sep 30 2021)

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Arena Pharmaceuticals Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ARNA's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ARNA's IV. Quarter Q/Q Revenue Comment


Arena Pharmaceuticals Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2021)		 12 Months Ending
(Sep 30 2021)		 12 Months Ending
(Jun 30 2021)		 12 Months Ending
(Mar 31 2021)		 12 Months Ending
(Dec 31 2020)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Dec 31 2021 period, Arena Pharmaceuticals Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Arena Pharmaceuticals Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Dec 31 2021 period, Arena Pharmaceuticals Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Arena Pharmaceuticals Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ARNA's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Dec 31 2021 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2021
Electrocore Inc 60.60%$ 60.600 millions
Koru Medical Systems Inc 59.97%$ 59.974 millions
Esperion Therapeutics Inc 59.79%$ 59.795 millions
Alnylam Pharmaceuticals Inc 58.07%$ 58.065 millions
Bionano Genomics Inc 57.99%$ 57.985 millions
Zynex inc 57.65%$ 57.653 millions
Hutchmed china Limited56.21%$ 56.213 millions
Aquestive Therapeutics Inc 54.96%$ 54.959 millions
Aptevo Therapeutics Inc 54.45%$ 54.446 millions
Natera Inc 53.97%$ 53.970 millions
Axonics Inc 52.76%$ 52.761 millions
Aytu Biopharma Inc52.67%$ 52.670 millions
Protagonist Therapeutics inc 52.51%$ 52.513 millions
Ionis Pharmaceuticals Inc 51.58%$ 51.579 millions
Steris Plc49.45%$ 49.454 millions
Twist Bioscience Corporation49.21%$ 49.206 millions
Dermtech Inc 49.15%$ 49.152 millions
Elite Pharmaceuticals Inc 48.43%$ 48.428 millions
Tela Bio Inc 47.77%$ 47.768 millions
Rayont Inc 47.28%$ 47.284 millions
Timber Pharmaceuticals Inc 46.96%$ 46.961 millions
Sanara Medtech Inc 46.86%$ 46.862 millions
Apyx Medical Corp46.76%$ 46.755 millions
Arena Pharmaceuticals Inc 45.95%$ 45.946 millions
Biolase Inc 45.62%$ 45.622 millions
Venus Concept Inc 45.52%$ 45.525 millions
Immucell Corporation45.43%$ 45.427 millions
Castle Biosciences Inc 44.74%$ 44.742 millions
Teladoc Health Inc 44.59%$ 44.588 millions
Rennova Health Inc 44.56%$ 44.562 millions


About Arena Pharmaceuticals Inc Revenue Growth Rates (ARNA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Arena Pharmaceuticals Inc (CIK 1080709).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001080709-22-000008
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Arena Pharmaceuticals Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.